Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for March 2, 2015

March 2, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

AngioDynamics looks to get in on EmboMedics

March 2, 2015 by Brad Perriello

AngioDynamics inks a deal to invest in EmboMedics and its ResoSphere resorbable embolic microsphere technology, with a possible acquisition on the table.

AngioDynamics looks to get in on EmboMedics

Sonova to move Swiss jobs and freeze pay to counter franc's surge

March 2, 2015 by MassDevice

Sonova Holding plans to move jobs out of Switzerland and freeze salaries there to cope with an unexpected surge in the value of the franc.

Sonova to move Swiss jobs and freeze pay to counter franc's surge

Tryton Medical's pivotal trial misses endpoint

March 2, 2015 by Brad Perriello

A pivotal trial of Tryton Medical's side-branch stent fails to meet its non-inferiority endpoint for target vessel failure, although most of the patients in the study fell outside its target parameters.

Tryton Medical's pivotal trial misses endpoint

A pivotal clinical trial of Tryton Medical's side-branch stent, the largest ever conducted on coronary bifurcation lesions, failed to meet its primary endpoint for target vessel failure.

Siemens investigates report of fictitious Chinese healthcare contracts

March 2, 2015 by MassDevice

Siemens says it's investigating a Chinese media report that its healthcare business inflated its numbers by citing faked contracts.

Siemens investigates report of fictitious Chinese contracts

(Reuters) — Germany's Siemens said it's investigating a media report that it boosted sales figures of its healthcare equipment in China by creating fake contracts.

FDA panel to review brain aneurysm devices

March 2, 2015 by Mark Hollmer

An FDA panel is slated to meet next month to evaluate the testing and use of flow diversion technology, the stent-like devices used to treat brain aneurysms.

FDA panel to review brain aneurysm devices

An FDA advisory panel is slated to meet in April to discuss flow diversion technology – stent-like devices used to treat brain aneurysms – and evaluate how they're designed and tested for human use.

Confirmed: Boston Scientific to buy Endo's urology portfolio for $1.65B

March 2, 2015 by Brad Perriello

Boston Scientific confirms speculation with a $1.65 billion bid for Endo International's urology business, not including its star-crossed American Medical Systems pelvic mesh business.

Boston Scientific to buy Endo's urology portfolio for $1.65B